Search

Author/Creator Azie, Nkechi

1. 123. Oral Ibrexafungerp Outcomes by Fungal Disease in Patients from an Interim Analysis of a Phase 3 Open-label Study (FURI). (4th December 2021)

Authors:
Pappas, Peter G; Cornely, Oliver; Koehler, Philipp; McCarty, Todd P; Alexander, Barbara D; Miller, Rachel; Vazquez, Jose A; Sanders, John W; Morse, Caryn; Ostrosky-Zeichner, Luis; Krause, Robert; Prattes, Jürgen; Spec, Andrej; Rautemaa-Richardson, Riina; Bazaz, Rohit; Walsh, Thomas J; Marty, Fran...
Journal:
Open forum infectious diseases
Issue:
Volume 8(2021)Supplement 1
Page Start:
S73
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 1248. Efficacy and Safety of Oral Ibrexafungerp in 41 Patients with Refractory Fungal Diseases, Interim Analysis of a Phase 3 Open-label Study (FURI). (31st December 2020)

Authors:
Alexander, Barbara D; Cornely, Oliver; Pappas, Peter; Miller, Rachel; Vazquez, Jose A; Ostrosky-Zeichner, Luis; Spec, Andrej; Rautemaa-Richardson, Riina; Krause, Robert; Thompson III, George R; Morse, Caryn; Sanders, John W; Andes, David; Andes, David; Lyon, George; Marty, Francisco M; Silverman,...
Journal:
Open forum infectious diseases
Issue:
Volume 7:Number 1(2020) Supplement
Page Start:
S642
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. 826Health Economic Outcome Analysis of patients randomized in the SECURE Phase III Trial comparing Isavuconazole to Voriconazole for primary treatment of Invasive fungal disease caused by Aspergillus Species or other filamentous Fungi. (December 2014)

Authors:
Khandelwal, Nikhil; Franks, Billy; Shi, Fei; Spalding, James; Azie, Nkechi
Journal:
Open forum infectious diseases
Issue:
Volume 1(2014)Supplement 1
Page Start:
S236
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. 992. Oral Ibrexafungerp Outcomes in Patients with Oropharyngeal and Esophageal Candidiasis from an Interim Analysis of a Phase 3 Open-label Study (FURI). (4th December 2021)

Authors:
Vazquez, Jose A; Cornely, Oliver; Koehler, Philipp; Rautemaa-Richardson, Riina; Bazaz, Rohit; Marshall Lyon, G; Marty, Francisco M; Gonzalez-Bocco, Isabel H; Miller, Rachel; Walsh, Thomas J; Pappas, Peter; McCarty, Todd P; Sanders, John W; Morse, Caryn; Ostrosky-Zeichner, Luis; Krause, Robert; Pr...
Journal:
Open forum infectious diseases
Issue:
Volume 8(2021)Supplement 1
Page Start:
S586
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗